DarioHealth Corp expected to post a loss of 12 cents a share - Earnings Preview

DarioHealth

12/05/2025 14:27

DarioHealth Corp DRIO.OQ DRIO.O is expected to show a rise in quarterly revenue when it reports  results on May 14 for the period ending March 31 2025

The New York City-based  company is expected to report a 29.8% increase in revenue to $7.475 million from $5.76 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

‚ÄčLSEG's mean analyst estimate for DarioHealth Corp is for a loss of 12 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ‚Äč

Wall Street's median 12-month price target for DarioHealth Corp is $2.00‚Äč, above‚Äč its last closing price of $0.75. ‚Äč‚Äč‚Äč

Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč

QUARTER ENDING
STARMINESMARTESTIMATE¬ģ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.34
-0.33
-0.09
Beat
73
Sep. 30 2024
-0.28
-0.27
-0.25
Beat
8.5
Jun. 30 2024
-0.55
-0.55
-0.08
Beat
85.6‚Äč
Mar. 31 2024
-0.48
-0.40
-0.20
Beat
50.6
‚Äč‚ÄčDec. 31 2023
-0.54
-0.55
-0.50
Beat
9.6
Sep. 30 2023
-0.48
-0.46
-0.49
Missed
-6.5‚Äč
Jun. 30 2023
-0.57
-0.52
-0.58
Missed
-11.1
Mar. 31 2023
-0.49
-0.50
-0.45
Beat
9.6

This summary was machine generated May 12 at 13:27 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)